Symbols / HURA $1.45 +2.84% TuHURA Biosciences, Inc.

Healthcare • Biotechnology • United States • NCM
HURA Chart
About

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-functional and bi-specific antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 92.19M
Enterprise Value 87.00M Income -30.06M Sales —
Book/sh 0.35 Cash/sh 0.06 Dividend Yield —
Payout 0.00% Employees 22 IPO —
P/E — Forward P/E -2.50 PEG —
P/S — P/B 4.17 P/C —
EV/EBITDA -3.10 EV/Sales — Quick Ratio 0.72
Current Ratio 0.78 Debt/Eq 3.34 LT Debt/Eq —
EPS (ttm) -0.63 EPS next Y -0.58 EPS Growth —
Revenue Growth — Earnings 2026-05-15 ROA -74.27%
ROE -169.18% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 63.58M
Shs Float 40.18M Short Float 15.60% Short Ratio 6.16
Short Interest — 52W High 4.44 52W Low 0.41
Beta — Avg Volume 1.69M Volume 1.73M
Target Price $8.62 Recom None Prev Close $1.41
Price $1.45 Change 2.84%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.63
Mean price target
2. Current target
$1.45
Latest analyst target
3. DCF / Fair value
$-1.35
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.45
Low
$7.50
High
$10.00
Mean
$8.63

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-03 reit HC Wainwright & Co. Buy → Buy $10
2026-01-09 reit HC Wainwright & Co. Buy → Buy $10
2025-11-14 main Maxim Group Buy → Buy $8
2025-05-16 reit HC Wainwright & Co. Buy → Buy $12
2025-04-03 main HC Wainwright & Co. Buy → Buy $12
2025-03-03 init HC Wainwright & Co. — → Buy $13
2024-12-19 init Rodman & Renshaw — → Buy $11
News
RSS: Latest HURA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-10-18 BIANCO JAMES A Chief Executive Officer — 2,323,307 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
27.29
+59.11%
17.15
+30.23%
13.17
+35.51%
9.72
Research And Development
20.53
+53.97%
13.34
+41.83%
9.40
+18.59%
7.93
Selling General And Administration
7.58
+95.77%
3.87
-6.53%
4.14
+106.69%
2.01
General And Administrative Expense
7.58
+95.77%
3.87
-6.53%
4.14
+106.69%
2.01
Other Gand A
7.58
+95.77%
3.87
-6.53%
4.14
+106.69%
2.01
Other Operating Expenses
-0.71
-1138.15%
-0.06
-35.70%
-0.04
+80.24%
-0.21
Total Expenses
27.29
+59.11%
17.15
+30.23%
13.17
+35.51%
9.72
Operating Income
-27.29
-59.11%
-17.15
-30.23%
-13.17
-35.51%
-9.72
Total Operating Income As Reported
-31.80
-80.15%
-17.65
+40.70%
-29.76
-199.63%
-9.93
EBITDA
-29.36
-68.45%
-17.43
+40.16%
-29.12
-223.76%
-8.99
Normalized EBITDA
-27.08
-62.43%
-16.67
-29.22%
-12.90
-38.92%
-9.29
Reconciled Depreciation
0.07
-38.94%
0.12
-34.20%
0.18
-52.46%
0.37
EBIT
-29.43
-67.73%
-17.54
+40.12%
-29.30
-212.76%
-9.37
Total Unusual Items
-2.27
-201.51%
-0.75
+95.35%
-16.22
-5614.90%
0.29
Total Unusual Items Excluding Goodwill
-2.27
-201.51%
-0.75
+95.35%
-16.22
-5614.90%
0.29
Special Income Charges
-3.86
-777.65%
-0.44
+97.28%
-16.22
-5614.90%
0.29
Other Special Charges
3.68
+735.63%
0.44
-97.28%
16.22
+5614.90%
-0.29
Restructuring And Mergern Acquisition
0.19
0.00
—
—
Write Off
—
—
—
0.00
Net Income
-30.05
-38.60%
-21.68
+26.04%
-29.32
-212.96%
-9.37
Pretax Income
-30.05
-38.60%
-21.68
+26.04%
-29.32
-212.96%
-9.37
Net Non Operating Interest Income Expense
-0.49
+87.05%
-3.78
-5420.38%
0.07
+23.77%
0.06
Interest Expense Non Operating
0.63
-84.89%
4.14
+22044.16%
0.02
0.00
Net Interest Income
-0.49
+87.05%
-3.78
-5420.38%
0.07
+23.77%
0.06
Interest Expense
0.63
-84.89%
4.14
+22044.16%
0.02
0.00
Interest Income Non Operating
0.14
-62.33%
0.36
+303.28%
0.09
+56.36%
0.06
Interest Income
0.14
-62.33%
0.36
+303.28%
0.09
+56.36%
0.06
Other Income Expense
-2.27
-201.51%
-0.75
+95.35%
-16.22
-5614.90%
0.29
Gain On Sale Of Security
1.59
+607.04%
-0.31
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-30.05
-38.60%
-21.68
+26.04%
-29.32
-212.96%
-9.37
Net Income From Continuing Operation Net Minority Interest
-30.05
-38.60%
-21.68
+26.04%
-29.32
-212.96%
-9.37
Net Income From Continuing And Discontinued Operation
-30.05
-38.60%
-21.68
+26.04%
-29.32
-212.96%
-9.37
Net Income Continuous Operations
-30.05
-38.60%
-21.68
+26.04%
-29.32
-212.96%
-9.37
Normalized Income
-27.78
-32.73%
-20.93
-59.77%
-13.10
-35.58%
-9.66
Net Income Common Stockholders
-30.06
-32.72%
-22.65
+22.74%
-29.32
-212.96%
-9.37
Otherunder Preferred Stock Dividend
0.00
-100.00%
0.97
0.00
—
Diluted EPS
-0.63
+47.93%
-1.21
+51.01%
-2.47
-221.06%
-0.77
Basic EPS
-0.63
+47.93%
-1.21
+51.01%
-2.47
-221.06%
-0.77
Basic Average Shares
47.93
+156.81%
18.66
+56.97%
11.89
-2.36%
12.18
Diluted Average Shares
47.93
+156.81%
18.66
+56.97%
11.89
-2.36%
12.18
Diluted NI Availto Com Stockholders
-30.06
-32.72%
-22.65
+22.74%
-29.32
-212.96%
-9.37
Other Taxes
-0.11
0.00
+100.00%
-0.33
0.00
Preferred Stock Dividends
0.01
+300.00%
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
27.35
+36.99%
19.97
+357.76%
4.36
-71.30%
15.20
Current Assets
4.62
-76.44%
19.61
+371.54%
4.16
-71.79%
14.74
Cash Cash Equivalents And Short Term Investments
3.62
-71.40%
12.66
+245.35%
3.67
-74.29%
14.25
Cash And Cash Equivalents
3.62
-71.40%
12.66
+245.35%
3.67
-74.29%
14.25
Receivables
0.50
+14.31%
0.44
+30.78%
0.33
+229.75%
0.10
Other Receivables
0.50
+124.52%
0.22
—
—
Taxes Receivable
0.00
-100.00%
0.21
-35.80%
0.33
—
Accrued Interest Receivable
—
—
0.10
+7022.47%
0.00
Prepaid Assets
0.17
-97.30%
6.20
0.00
—
Other Current Assets
0.33
+5.43%
0.32
+98.56%
0.16
-67.60%
0.49
Total Non Current Assets
22.73
+6280.11%
0.36
+75.52%
0.20
-55.12%
0.45
Net PPE
0.69
+112.44%
0.32
+58.89%
0.20
-51.50%
0.42
Gross PPE
2.84
+18.00%
2.41
+10.87%
2.17
-1.73%
2.21
Accumulated Depreciation
-2.16
-3.41%
-2.09
-5.92%
-1.97
-9.89%
-1.79
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.91
+14.92%
1.67
+3.60%
1.61
+5.18%
1.53
Other Properties
0.38
+93.08%
0.20
+856.58%
0.02
-84.94%
0.14
Leases
0.54
+0.00%
0.54
+0.00%
0.54
+0.00%
0.54
Goodwill And Other Intangible Assets
22.01
0.00
—
—
Goodwill
10.74
0.00
—
—
Other Intangible Assets
11.28
—
—
—
Other Non Current Assets
0.03
+0.00%
0.03
—
0.03
Total Liabilities Net Minority Interest
6.42
+19.51%
5.37
-9.25%
5.92
+104.67%
2.89
Current Liabilities
5.92
+11.06%
5.33
+48.20%
3.60
+25.23%
2.87
Payables And Accrued Expenses
4.00
-0.27%
4.01
+98.13%
2.02
-2.71%
2.08
Payables
3.77
+19.58%
3.15
+68.89%
1.87
-2.56%
1.92
Accounts Payable
3.77
+19.58%
3.15
+68.89%
1.87
-2.56%
1.92
Other Payable
—
—
—
—
Current Accrued Expenses
0.23
-73.40%
0.86
+447.12%
0.16
-4.45%
0.16
Pensionand Other Post Retirement Benefit Plans Current
1.53
+31.29%
1.16
-17.93%
1.42
+109.69%
0.68
Current Debt And Capital Lease Obligation
0.40
+147.99%
0.16
+667.74%
0.02
-82.28%
0.12
Current Debt
0.20
—
—
—
Other Current Borrowings
—
—
—
—
Current Capital Lease Obligation
0.20
+24.52%
0.16
+667.74%
0.02
-82.28%
0.12
Other Current Liabilities
—
—
0.14
—
Total Non Current Liabilities Net Minority Interest
0.50
+1074.64%
0.04
-98.16%
2.32
+11104.54%
0.02
Long Term Debt And Capital Lease Obligation
0.30
+611.10%
0.04
-98.16%
2.32
+11104.54%
0.02
Long Term Debt
—
—
2.32
—
Long Term Capital Lease Obligation
0.30
+611.10%
0.04
0.00
-100.00%
0.02
Non Current Deferred Liabilities
0.20
0.00
—
—
Non Current Deferred Taxes Liabilities
0.20
0.00
—
—
Stockholders Equity
20.93
+43.43%
14.59
+1036.26%
-1.56
-112.67%
12.30
Common Stock Equity
20.65
+44.28%
14.32
+1008.54%
-1.58
-112.81%
12.30
Capital Stock
0.34
+5.30%
0.32
+1003.31%
0.03
+130.97%
0.01
Common Stock
0.06
+40.19%
0.04
+247.83%
0.01
+168.67%
0.00
Preferred Stock
0.28
+0.00%
0.28
+1546.84%
0.02
+109.79%
0.01
Share Issued
59.34
+40.20%
42.32
+0.70%
42.03
+0.00%
42.03
Ordinary Shares Number
59.34
+40.20%
42.32
+0.70%
42.03
+0.00%
42.03
Additional Paid In Capital
161.78
+29.01%
125.40
+44.32%
86.89
+21.61%
71.45
Retained Earnings
-141.18
-27.05%
-111.12
-25.60%
-88.47
-49.56%
-59.16
Total Equity Gross Minority Interest
20.93
+43.43%
14.59
+1036.26%
-1.56
-112.67%
12.30
Total Capitalization
20.93
+43.43%
14.59
+1806.68%
0.77
-93.78%
12.30
Working Capital
-1.30
-109.09%
14.28
+2439.09%
0.56
-95.26%
11.87
Invested Capital
20.85
+45.65%
14.32
+1812.55%
0.75
-93.91%
12.30
Total Debt
0.70
+245.62%
0.20
-91.36%
2.34
+1596.51%
0.14
Capital Lease Obligations
0.50
+148.18%
0.20
+872.82%
0.02
-84.94%
0.14
Net Tangible Assets
-1.08
-107.41%
14.59
+1036.26%
-1.56
-112.67%
12.30
Tangible Book Value
-1.36
-109.50%
14.32
+1008.54%
-1.58
-112.81%
12.30
Current Notes Payable
0.20
0.00
—
0.00
Notes Receivable
—
—
0.10
+0.00%
0.10
Preferred Stock Equity
0.28
+0.00%
0.28
+1546.84%
0.02
+109.79%
0.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-27.63
-87.59%
-14.73
-23.24%
-11.95
-59.17%
-7.51
Cash Flow From Continuing Operating Activities
-27.63
-87.59%
-14.73
-23.24%
-11.95
-59.17%
-7.51
Net Income From Continuing Operations
-30.05
-38.60%
-21.68
+26.04%
-29.32
-212.96%
-9.37
Depreciation Amortization Depletion
0.07
-38.94%
0.12
-34.20%
0.18
-52.46%
0.37
Depreciation And Amortization
0.07
-38.94%
0.12
-34.20%
0.18
-52.46%
0.37
Other Non Cash Items
0.67
-47.87%
1.28
+24849.73%
0.01
—
Stock Based Compensation
6.42
+228.02%
1.96
+309.00%
0.48
+119.40%
0.22
Asset Impairment Charge
—
0.00
-100.00%
16.22
0.00
Operating Gains Losses
—
0.31
—
-0.29
Gain Loss On Investment Securities
—
0.31
—
—
Unrealized Gain Loss On Investment Securities
-1.59
0.00
—
—
Change In Working Capital
-3.15
-195.80%
3.29
+574.97%
0.49
-68.83%
1.56
Change In Payables And Accrued Expense
-3.76
-203.19%
3.64
+979.19%
0.34
-81.73%
1.85
Change In Other Working Capital
—
—
—
—
Change In Other Current Assets
0.61
+270.94%
-0.36
-340.20%
0.15
+152.07%
-0.29
Change In Other Current Liabilities
—
—
—
0.07
Investing Cash Flow
-1.34
+77.94%
-6.05
-366.69%
-1.30
-3474.93%
-0.04
Cash Flow From Continuing Investing Activities
-1.34
+77.94%
-6.05
-366.69%
-1.30
-3474.93%
-0.04
Net PPE Purchase And Sale
-0.08
-31.39%
-0.06
+26.91%
-0.08
-118.39%
-0.04
Purchase Of PPE
-0.08
-31.39%
-0.06
+26.91%
-0.08
-118.39%
-0.04
Capital Expenditure
-0.08
-31.39%
-0.06
+26.91%
-0.08
-118.39%
-0.04
Net Business Purchase And Sale
-1.26
+78.99%
-5.99
-392.30%
-1.22
0.00
Purchase Of Business
-1.26
+78.99%
-5.99
-392.30%
-1.22
0.00
Financing Cash Flow
19.93
-33.07%
29.77
+1019.17%
2.66
-83.63%
16.25
Cash Flow From Continuing Financing Activities
19.93
-33.07%
29.77
+1019.17%
2.66
-83.63%
16.25
Net Issuance Payments Of Debt
0.62
-97.84%
28.57
+963.99%
2.69
+867.14%
-0.35
Issuance Of Debt
3.00
-89.50%
28.57
+963.99%
2.69
0.00
Repayment Of Debt
-2.38
0.00
0.00
+100.00%
-0.35
Long Term Debt Issuance
3.00
-89.50%
28.57
+963.99%
2.69
0.00
Long Term Debt Payments
-2.38
0.00
—
—
Net Long Term Debt Issuance
0.62
-97.84%
28.57
+963.99%
2.69
0.00
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
0.00
+100.00%
-0.35
Net Short Term Debt Issuance
—
—
0.00
+100.00%
-0.35
Net Common Stock Issuance
18.30
+266.07%
5.00
+20301.20%
-0.02
0.00
Common Stock Payments
—
0.00
+100.00%
-0.02
0.00
Cash Dividends Paid
-0.01
0.00
—
—
Repurchase Of Capital Stock
—
0.00
+100.00%
-0.02
0.00
Proceeds From Stock Option Exercised
3.62
+76.72%
2.05
0.00
—
Net Other Financing Charges
-2.61
+55.42%
-5.84
—
—
Changes In Cash
-9.04
-200.50%
8.99
+184.93%
-10.59
-221.60%
8.71
Beginning Cash Position
12.66
+245.35%
3.67
-74.29%
14.25
+156.98%
5.55
End Cash Position
3.62
-71.40%
12.66
+245.35%
3.67
-74.29%
14.25
Free Cash Flow
-27.71
-87.37%
-14.79
-22.91%
-12.03
-59.45%
-7.54
Interest Paid Supplemental Data
0.06
0.00
—
—
Common Stock Issuance
18.30
+266.07%
5.00
0.00
0.00
Issuance Of Capital Stock
18.30
+266.07%
5.00
0.00
-100.00%
16.60
Net Preferred Stock Issuance
—
—
0.00
-100.00%
16.60
Preferred Stock Dividend Paid
-0.01
0.00
—
—
Preferred Stock Issuance
—
—
0.00
-100.00%
16.60
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category